Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lalit Sehgal
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University Wexner Medical Center,
The Ohio State University
ORCID:
0000-0002-1151-5427
Observed ORCID:
0000-0002-1151-5427
OpenAlex ID:
A5026567340
BET inhibition blunts antibody production and macrophage-mediated fibrosis to restore lung function in murine cGVHD
2026
·
Rathan Kumar
, Lotus Neidemire-Colley
, et al.
·
Blood
·
3
Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy Is Associated with Inferior Survival for Patients with Relapsed or Refractory Large B-Cell Lymphoma
2024
·
John Sharp
, Qiuhong Zhao
, et al.
·
Blood
·
1
Abstract 1422: Fibroblast growth factor receptor-1 is a novel therapeutic target in mantle cell Lymphoma
2023
·
Anuvrat Sircar
, Satishkumar Singh
, et al.
·
Cancer Research
·
1
Abstract 4490: PRMT5 inhibition alters cellular chromatin landscape and drives vulnerability to BH3 mimetics in mantle cell lymphoma.
2026
·
Christoph Weigel
, Claire Hinterschied
, et al.
·
Cancer Research
BET Inhibition Blunts Antibody Production and Macrophage Mediated Fibrosis to Restore Lung Function in Murine Bronchiolitis Obliterans Chronic GVHD
2026
·
Rathan Kumar
, Lotus Neidemire-Colley
, et al.
·
Transplantation and Cellular Therapy
Uncovering survival-linked genes in DLBCL: A transcriptomic analysis of 1,311 patients
2025
·
Fahad Ahmed
, Yibin Yang
, et al.
·
Blood
PDF
Machine learning based survival prediction of DLBCL: Using multimodal data.
2025
·
Fahad Ahmed
, Zachary Frosch
, et al.
·
Blood
PDF
Tumor Microenvironment-Induced Interleukin-6 Regulates Proliferation and Survival in Patients with Mantle Cell Lymphoma (MCL) By Activating FGFR1 Signaling
2024
·
Yuangfeng Wang
, Satishkumar Singh
, et al.
·
Blood
Transcriptomic Analysis in Mantle Cell Lymphoma Patients Identified MALAT1 Long-Non-Coding RNA to Regulate Cell Cycle Progression By Modulating EZH2/p57/Sox11 Axis
2024
·
Satishkumar Singh
, Alessandro La Ferlita
, et al.
·
Blood
PDF
Targeting the DNA Damage Response through TBL1X in Mantle Cell Lymphoma
2024
·
Betsy A Pray
, Ethan Baiocchi
, et al.
·
Blood
PDF
Transcriptome Analysis at Locus-Specific Resolution Identified Alteration in Human Endogenous Retroviruses, a Class of Transposable Elements in Mantle Cell Lymphoma
2024
·
Alessandro La Ferlita
, Nicholas Staudinger
, et al.
·
Blood
Abstract 4432: Molecular biomarkers of non-Hodgkin lymphomas and subtypes identified by mass spectrometry-based metabolomics
2024
·
Fouad Choueiry
, Satishkumar Singh
, et al.
·
Cancer Research
Abstract 2997: Identification of novel long non-coding RNAs in mantle cell lymphoma patients
2024
·
Alessandro LaFerlita
, Satishkumar Singh
, et al.
·
Cancer Research
Abstract 3689: Uncovering the metabolic vulnerabilities in activated B cell diffuse large B cell lymphoma
2023
·
Satishkumar Singh
, Fouad Choueiry
, et al.
·
Cancer Research
Impact of Circulating Lymphoma at Diagnosis on Outcomes in Patients with Diffuse Large B-Cell Lymphoma
2022
·
Srichandhana Rajamouli
, Eric McLaughlin
, et al.
·
Blood
Nanochip Technology for Monitoring Chemotherapy Response Using Extracellular RNAs and Proteins in Patient Plasma with Diffuse Large B-Cell Lymphoma As Biomarkers
2022
·
Narendranath Epperla
, Xinyu Wang
, et al.
·
Blood
Show more works
View as search
Works count:
16
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type